Margaret Ann Snowden
Aeras(US)
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Immunodeficiency and Autoimmune Disorders, Mycobacterium research and diagnosis, Immune responses and vaccinations, Cytomegalovirus and herpesvirus research
Most-Cited Works
- → Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial(2013)1,027 cited
- → T-cell activation is an immune correlate of risk in BCG vaccinated infants(2016)268 cited
- → First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults(2015)191 cited
- → The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial(2018)159 cited
- → Cytomegalovirus infection is a risk factor for tuberculosis disease in infants(2019)61 cited
- → The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responses(2014)50 cited
- → The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4+ T cell counts >350 cells/mm3(2015)43 cited
- → Innovative clinical trial designs to rationalize TB vaccine development(2015)39 cited
- → Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial(2017)35 cited
- → Cytomegalovirus infection is a risk factor for TB disease in Infants(2017)24 cited